Epilepsy encompasses a spectrum of seizure disorders, each presenting unique challenges in diagnosis and management. Zarqa’s Epilepsy Panel offers a comprehensive approach, targeting various seizure syndromes and associated genetic factors to provide accurate diagnoses and tailored treatment strategies.
Our panel is designed to cover different types of seizure syndromes, including Dravet syndrome, early infantile epileptic encephalopathy, myoclonic epilepsy, and more.
With 783 genes analyzed, including mitochondrial and nuclear mitochondrial genes, our panel ensures thorough examination of genetic factors contributing to epilepsy and related disorders.
Utilizing Next-Generation Sequencing (NGS) with CNV analysis and repeat expansion analysis for precise and reliable results.
Results delivered within 30 business days, enabling timely diagnosis and intervention for patients.
And more…
Sample Requirements:
Coverage:
Discover our advanced genomic testing services tailored for your specific needs. Contact us today to enhance your research with unparalleled accuracy and expertise.
Get The Latest Updates via email. Any time you may unsubscribe
Copyright © 2024 Zarqa Genomics Lab, All rights reserved